
Audicin
Neurotechnology company developing real-time nervous system regulation tools using science-based audio.
About
Audicin is a Finland-based neurotechnology company that develops real-time nervous system regulation tools. Their technology leverages brainwave entrainment, auditory engineering, and music neuroscience to enhance focus, stress recovery, productivity, and sleep. Audicin's solutions deliver adaptive background listening sessions that respond to physiological signals, enabling continuous nervous system regulation.
Key facts
At-a-glance profile data
- Website
- audicin.com
- Headquarters
- Helsinki, Finland
- Founded
- 2022
- Employees
- 17
- Total funding
- $2M (Funding Round)
- Business model
- B2B2C
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Apr 2026 | Funding Round | $2M | - |
| 6 Jun 2024 | Seed | $565K | Petteri Lahtela, Virpi Tuomivaara |
Tech stack
Detected on audicin.com, last scanned 17 Sept 2026. Run your own scan
- Analytics
- Google Tag Manager
- CMS / Builders
- Webflow, Shopify
- CDN
- Cloudflare
- Email provider
- Google Workspace
- Cookie consent
- Cookiebot
Frequently asked
What does Audicin do?
Key offerings include Audicin for Apps, an SDK for integrating regulation protocols into digital health and consumer platforms, and a standalone Sleep Headband for offline use in environments with mobile device restrictions. The company is focused on embedding nervous system support into everyday contexts and has early commercial traction in defense, performance, and wellness sectors.
How much funding has Audicin raised?
Audicin has raised a total of $2M in funding. The most recent round on record is Funding Round.
How many employees does Audicin have?
Audicin has approximately 17 people on record.